Open AccessErlotinib May be More Effective for Central Nervous Metastasis of Lung Adenocarcinoma Than Gefitinib Because of the Difference in the Clinical Regimes
Author(s) -
Imahashi
Publication year - 2011
Publication title -
journal of medical cases
Language(s) - English
Resource type - Journals
eISSN - 1923-4163
pISSN - 1923-4155
DOI - 10.4021/jmc253w
Subject(s) - gefitinib , erlotinib , medicine , brain metastasis , adenocarcinoma , lung cancer , adenocarcinoma of the lung , lung , central nervous system , oncology , metastasis , epidermal growth factor receptor , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom